Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rofil Medical
Breda, North Brabant, Netherlands
- Ownership
- Private
- Development stage
- Other
01
Overview
Rofil Medical was a Dutch medical device company specializing in products for aesthetic and reconstructive surgery. The company's flagship product was Artecoll, a permanent dermal filler consisting of polymethylmethacrylate (PMMA) microspheres suspended in a collagen solution. Rofil Medical also distributed breast implants under the brand name M-implants, which were later revealed to be manufactured by the disgraced French firm Poly Implant Prothèse (PIP). Due to the fallout from the PIP scandal and other regulatory hurdles, the company declared bankruptcy in 2009 and is no longer active. Its PMMA filler technology eventually became the basis for Bellafill in the United States.
- Therapeutic areas
- Dermatology
- Modalities
- Device
- Industry
- Implantable Medical Devices
02
Partnerships
Poly Implant Prothèse (PIP)
Beyond the preview
Go deeper on Rofil Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rofil Medical.